NL-OMON51872招募中不适用
The value of a risk prediction tool (PERSARC) for effectvie treatment decision making: a stepped wedge Randomized Controlled Trial. - VALUE-PERSARC
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients >= 18 years
- •Histologically diagnosed with grade 2-3 STS in their extremities.
- •Who do not have a treatment plan yet
- •Dutch fluency and literacy
- •Mentally competent
- •Signed informed consent
- •- Patient owns smartphone with internet access (WiFi)
排除标准
- •Patient that are treated without curative intent
- •Patient that needs to be treated with chemotherapy or isolated limb perfusion
- •Patients were surgery is not indicated
- •Sarcoma subtypes not mentioned in the PERSARC app
- •In summary: patients with sarcoma subtypes and/or patients that need to be
- •treated with other treatment modalities than those mentioned in the PERSARC app
- •are excluded.
研究者
相似试验
尚未招募
不适用
The value of a risk prediction tool (PERSARC) for effective treatment decisions of soft tissue sarcomas patients.grade 2-3 soft tissue extremity sarcomaNL-OMON24454KWF kankerbestrijding231
进行中（未招募）
不适用
The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas PatientsSoft-tissue SarcomaPredictive Cancer ModelNCT05741944Leiden University Medical Center120
尚未招募
不适用
A risk-predictive score for developing Non-Alcoholic Fatty Liver Disease (NAFLD) using biochemical markersCTRI/2022/12/048328PG Grants, Kasturba Medical College
招募中
不适用
*The PreRisk calculator in suspected or confirmed preeclampsia: A new tool to safely reduce the number of unnecessary admissions*NL-OMON48687Erasmus MC, Universitair Medisch Centrum Rotterdam864
招募中
不适用
The PreRisk calculator in suspected or confirmed preeclampsia: A new tool to safely reduce the number of unnecessary admissions’NL-OMON22891one864